Michael Liebman has resigned as global director of bioinformatics at Roche Bioscience. Disappointed with the pharma industry’s focus on drug development instead of disease treatment, he left Roche to join the University of Pennsylvania Medical School as director of computational biology and professor of cancer biology.
“I’m committed to the integration of diagnostics and therapeutics, and I don’t find that the pharmaceutical industry has really bought into that model yet,” he said.
Liebman will also act as chief scientific officer for Genmatics, a new joint venture between Motorola’s global software group and Medical Science Associates. He also plans to do consulting work for companies in his areas of interest.
Before his Roche days, Liebman was head of bioinformatics for Wyeth-Ayerst for two years. He also directed bioinformatics and genomics at Vysis/Amoco for seven years.
Informatics provider Scimagix of Redwood Shores, Calif., has hired Jeffrey Moore as director of database engineering and Mark Meyers as vice president of sales. Moore and Meyers will help develop and sell the company’s Scientific Image Management System.
Moore was formerly vice president of cheminformatics at Oxford Molecular Group where he led the development of the RS3 Discovery cheminformatics system.
Meyers was vice president of business development at EMAX Solutions and was Oxford’s US sales director before that.
Scott Patterson has joined Celera Genomics as senior director, proteomics. One of his first tasks will be to finish building the laboratory infrastructure at the company’s proteomics facility. Formerly Amgen’s associate director of research and head of its biochemistry and genetics department, Patterson said he plans to hire 60 new employees, including LIMS experts, cell biologists, protein chemists, and mass spectrometry specialists.